Sodium-Glucose Cotransporter-2 Inhibitors Improve Cardiovascular Dysfunction in Type 2 Diabetic East Asians
Afzal, M.; Al-Abbasi, F.A.; Nadeem, M.S.; Alshehri, S.; Ghoneim, M.M.; Imam, S.S.; Almalki, W.H.; Kazmi, I. Sodium-Glucose Cotransporter-2 Inhibitors Improve Cardiovascular Dysfunction in Type 2 Diabetic East Asians. Metabolites 2021, 11, 794. https://doi.org/10.3390/metabo11110794
Afzal M, Al-Abbasi FA, Nadeem MS, Alshehri S, Ghoneim MM, Imam SS, Almalki WH, Kazmi I. Sodium-Glucose Cotransporter-2 Inhibitors Improve Cardiovascular Dysfunction in Type 2 Diabetic East Asians. Metabolites. 2021; 11(11):794. https://doi.org/10.3390/metabo11110794
Chicago/Turabian StyleAfzal, Muhammad, Fahad A. Al-Abbasi, Muhammad Shahid Nadeem, Sultan Alshehri, Mohammed M. Ghoneim, Syed Sarim Imam, Waleed Hassan Almalki, and Imran Kazmi. 2021. "Sodium-Glucose Cotransporter-2 Inhibitors Improve Cardiovascular Dysfunction in Type 2 Diabetic East Asians" Metabolites 11, no. 11: 794. https://doi.org/10.3390/metabo11110794